372 related articles for article (PubMed ID: 15664483)
1. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
2. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
[TBL] [Abstract][Full Text] [Related]
3. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
[TBL] [Abstract][Full Text] [Related]
4. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
[TBL] [Abstract][Full Text] [Related]
7. Infectivity of five different types of macrophages by Leishmania infantum.
Maia C; Rolão N; Nunes M; Gonçalves L; Campino L
Acta Trop; 2007 Aug; 103(2):150-5. PubMed ID: 17626776
[TBL] [Abstract][Full Text] [Related]
8. Activity of (-)alpha-bisabolol against Leishmania infantum promastigotes.
Morales-Yuste M; Morillas-Márquez F; Martín-Sánchez J; Valero-López A; Navarro-Moll MC
Phytomedicine; 2010 Mar; 17(3-4):279-81. PubMed ID: 19577452
[TBL] [Abstract][Full Text] [Related]
9. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.
Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P
Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
13. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
14. In vitro study of the anti-leishmanial activity of biodegradable nanoparticles.
Venier-Julienne MC; Vouldoukis I; Monjour L; Benoit JP
J Drug Target; 1995; 3(1):23-9. PubMed ID: 7655817
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis.
Machado PA; Hilário FF; Carvalho LO; Silveira ML; Alves RB; Freitas RP; Coimbra ES
Chem Biol Drug Des; 2012 Nov; 80(5):745-51. PubMed ID: 22882996
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
20. Changes in the proteome and infectivity of Leishmania infantum induced by in vitro exposure to a nitric oxide donor.
Dea-Ayuela MA; Ordoñez-Gutierrez L; Bolás-Fernández F
Int J Med Microbiol; 2009 Mar; 299(3):221-32. PubMed ID: 18774335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]